Stay updated on Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The website has been updated to version v2.10.3, with the removal of the section on 'Helpful Links Provided by Cantargia AB FDA Recalls, Market Withdrawals, and Safety Alerts' from the previous version v2.10.2.
    Difference
    0.5%
    Check dated 2024-09-04T05:08:39.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The website has added new content, while the FDA Safety Alerts and Recalls section has been removed.
    Difference
    0.2%
    Check dated 2024-08-28T02:41:51.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-13T23:32:39.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2024-08-06T22:28:18.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2024-07-30T22:27:53.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2024-07-29T21:18:13.000Z thumbnail image

Stay in the know with updates to Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.